SOURCE: Implant Sciences

Implant Sciences

September 06, 2011 07:00 ET

Implant Sciences Receives $1.1 Million Explosives Trace Detection Order

Quantum Sniffer QS-H150 Units Bound for Middle East Location

WILMINGTON, MA--(Marketwire - Sep 6, 2011) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced a $1.1 million order for its Quantum Sniffer™ QS-H150 portable explosives trace detection (ETD) system. The QS-H150 units will be deployed at critical infrastructure applications in the Middle East.

With more than 1,300 units sold, the QS-H150 has been adopted by a growing number of commercial and governmental security organizations around the world. It is deployed in a wide variety of applications including aviation security, transportation security, cargo screening, force protection, VIP protection, and public safety.

"Unfortunately as ongoing threats of violence disrupt daily life in the Middle East, the need for portable explosives trace detection technology is increasing. The Quantum Sniffer is an excellent choice to improve security coverage because our QS-H150 has been uniquely engineered to reduce dirt and contamination clogging problems caused by sand and dust, which makes the unit highly available with little or no downtime required for system calibration or clear down following an alarm," remarked Bruce Bower, Senior Vice President at Implant Sciences.

Implant Sciences' CEO, Glenn D. Bolduc, commented, "With automatic self-calibration, non-contact sampling, and no radioactive materials, the innovative QS-H150 continues to attract attention from new customers. We are very proud of the work our sales team and channel partners have invested in discovering this new opportunity."

About the Quantum Sniffer QS-H150

The QS-H150 Quantum Sniffer is a hand-held explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives. The QS-H150 features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability and extremely low total cost of ownership.

About the Quantum Sniffer QS-B220

The QS-B220 Quantum Sniffer, introduced in May 2011, is a bench-top explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, or homemade explosives and narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    Email Contact


    Investor Contact:
    Laurel Moody
    Email Contact